Evaluating the tolerability of the newer mood stabilizers

被引：3
|
作者：
Aloa, AO [1 ]
Dewan, MJ [1 ]
机构：
[1] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA
来源：
JOURNAL OF NERVOUS AND MENTAL DISEASE | 2001年 / 189卷 / 01期
关键词：
D O I：
10.1097/00005053-200101000-00012
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：60 / 63
页数：4
相关论文
共 50 条
  • [1] Evaluating the tolerability of the newer mood stabilizers (vol 189, pg 60, 2001)
    Aloa, AO
    Dewan, MJ
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2001, 189 (05) : 327 - 327
  • [2] Evaluating the tolerability of the newer antidepressants
    Dewan, MJ
    Anand, VS
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1999, 187 (02) : 96 - 101
  • [3] The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder
    Abelli, M
    Martini, C
    Pini, S
    Gesi, C
    Cassano, GB
    CURRENT DRUG TARGETS, 2005, 6 (05) : 607 - 614
  • [4] Effectiveness and tolerability of carbamazepine vs. oxcarbazepine as mood stabilizers
    Alvarez, G
    Marsh, W
    Camacho, IA
    Gracia, SL
    CLINICAL RESEARCH AND REGULATORY AFFAIRS, 2003, 20 (04) : 365 - 372
  • [5] Using the newer pharmacotherapeutic agents as mood stabilizers in bipolar spectrum disorders - Introduction
    Chengappa, KNR
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 3 - 4
  • [6] Advances in Mood Disorder Pharmacotherapy: Evaluating New Antipsychotics and Mood Stabilizers for Bipolar Disorder and Schizophrenia
    Kowalczyk, Emilia
    Koziej, Sylwia
    Soroka, Ewelina
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [7] ANTIEPILEPTICS AS MOOD STABILIZERS
    Danevski, G.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [8] Mood stabilizers: anticonvulsants
    E Agelopoulos
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [9] Mood stabilizers and anticonvulsants
    Kowatch, RA
    Bucci, JP
    PEDIATRIC CLINICS OF NORTH AMERICA, 1998, 45 (05) : 1173 - +
  • [10] Mood stabilizers and neurogenesis
    Chen, G.
    Schloesser, R.
    Manji, H. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S87 - S87
12345